Omalizumab (anti-IgE)

Catalog No.A2044        Batch: A204401

Print

Technical Data

CAS No. 242138-07-4
Formulation 100 mM Pro-Ac, 20 mM Arg, pH 5.0
Isotype Human IgG1
Application Omalizumab (anti-IgE)
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Purity 98%
Protein concentration 3.3mg/ml
Endotoxin Level <1EU/mg

Biological Activity

Description Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research.
In vivo

Omalizumab (anti-IgE) is effective in controlling the allergic symptoms of allergic rhinitis by lowering inflammatory mediator CysLT levels of nasal lavage in an experimental allergic rhinitis model.[1]

Protocol (Only for Reference)

Animal Study:
  • Animal models: Sprague Dawley rats
    Dosages: 0.5mg
    Administration: s.c.

    [1]

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.